Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: CytoTools Starts New European Clinical Trial In Indication Of Diabetic Foot Syndrome For DermaPro

Dec 21 (Reuters) - CYTOTOOLS AG  T5OG.DE : 
    * STARTS NEW EUROPEAN CLINICAL TRIAL IN INDICATION OF 
DIABETIC 
FOOT SYNDROME FOR DERMAPRO 
 
Source text for Eikon:  ID:nEQklbk5a  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on bioXXmed AG

See all news